Henan Lingrui Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
Henan Lingrui Pharmaceutical Stock Forecast and Price Target
Given the average yearlong price target of ¥9.91 provided by prominent analysts over the past few months, there is a potential downside of approximately -60.12% from the last closing price in May, 2024 for Henan Lingrui Pharmaceutical's stock if it is reached. This estimation is based on a high estimate of ¥11.10 and a low estimate of ¥8.82. If you're interested in 600285 stock, looking at its competitors might also be a good idea.
-60.12% Downside
Henan Lingrui Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Henan Lingrui Pharmaceutical's Price has decreased by 100.00%, going from ¥11.23 to ¥0.00. In the next year, analysts believe that Fair Value will reach ¥19.82 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600276 Stock Forecast | Jiangsu Hengrui Medicine | Buy |
15
|
¥44.75 | Buy/Sell | ¥56.49 | 20.67% |
| T14 Stock Forecast | Tianjin Pharmaceutical Da Ren ... | Outperform |
18
|
$35.79 | Buy/Sell | $1.70 | 27.97% |
| 600436 Stock Forecast | Zhangzhou Pientzehuang Pharmac... | Outperform |
18
|
¥237.10 | Buy/Sell | ¥302.86 | 18.63% |
| 000538 Stock Forecast | Yunnan Baiyao Group Co.,Ltd | Outperform |
18
|
¥55.31 | Buy/Sell | ¥65.39 | 17.23% |
| 1093 Stock Forecast | CSPC Pharmaceutical Group | Buy |
18
|
HK$6.62 | Buy/Sell | HK$9.50 | 40.18% |
Henan Lingrui Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Henan Lingrui Pharmaceutical's Revenue has grown, rising from ¥2.33B to ¥3.31B – a growth of 42.03%. 0 analysts predict Henan Lingrui Pharmaceutical's Revenue will decrease by 11.02% in the next year, reaching ¥2.95B. By 2030, professionals predict that Henan Lingrui Pharmaceutical's Revenue will decrease by 10.67%, to ¥2.96B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600085 Stock Forecast | Beijing Tongrentang | Outperform |
16
|
¥46.33 | Buy/Sell | ¥61.18 | 20.87% |
| 000999 Stock Forecast | China Resources Sanjiu Medical... | Buy |
18
|
¥61.80 | Buy/Sell | ¥65.95 | 10.26% |
| 600196 Stock Forecast | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥23.78 | Buy/Sell | ¥33.57 | 9.76% |
.jpg)
Henan Lingrui Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
Henan Lingrui Pharmaceutical's Dividend per Share has grown In the last two years, rising from ¥0.40 to ¥0.60 – a growth of 50.00%. In the next year, analysts believe that Dividend per Share will reach ¥0.88 – an increase of 46.67%. For the next seven years, experts predict that Henan Lingrui Pharmaceutical's Dividend per Share will grow at a rate of 43.52%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 002294 Stock Forecast | Shenzhen Salubris Pharmaceutic... | Buy |
18
|
¥29.56 | Buy/Sell | ¥35.65 | 25.17% |
| 600079 Stock Forecast | Humanwell Healthcare (Group) | Buy |
0
|
¥20.28 | Buy/Sell | ¥32.49 | -48.03% |
| 000513 Stock Forecast | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | Buy/Sell | ¥39.23 | 11.41% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300146 Stock Forecast | Byhealth | Outperform |
15
|
¥15.91 | Buy/Sell | ¥26.39 | 28.85% |
| 600518 Stock Forecast | Kangmei Pharmaceutical | - |
6
|
¥1.95 | Buy/Sell | ¥25.97 | -100.00% |
| 002262 Stock Forecast | Jiangsu Nhwa Pharmaceutical Co... | Buy |
18
|
¥23.69 | Buy/Sell | ¥31.34 | 30.86% |
Henan Lingrui Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Henan Lingrui Pharmaceutical's EBITDA has grown by 74.84%, rising from ¥392.06M to ¥685.49M. For the next year, analysts predict that EBITDA will reach ¥716.00M – an increase of 4.45%. Over the next seven years, experts believe that Henan Lingrui Pharmaceutical's EBITDA will grow at a rate of 5.69%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 900904 Stock Forecast | Shanghai Shenqi Pharmaceutical... | - |
13
|
$6.58 | Buy/Sell | $0.00 | -100.00% |
| 600062 Stock Forecast | China Resources Double-Crane P... | Buy |
16
|
¥22.64 | Buy/Sell | ¥26.00 | 13.69% |
| 600380 Stock Forecast | Joincare Pharmaceutical Group ... | Buy |
18
|
¥11.61 | Buy/Sell | ¥14.72 | 26.79% |
Henan Lingrui Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Henan Lingrui Pharmaceutical's EBIT has grown, moving from ¥323.60M to ¥609.68M – an increase of 88.41%. In the next year, analysts predict that EBIT will jump to ¥724.00M – up 18.75% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 54.03%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 002773 Stock Forecast | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥22.71 | Buy/Sell | ¥24.00 | -100.00% |
| 600867 Stock Forecast | Tonghua Dongbao Pharmaceutical | Outperform |
18
|
¥10.08 | Buy/Sell | ¥14.25 | 41.07% |
| 603858 Stock Forecast | Shandong Buchang Pharmaceutica... | - |
18
|
¥16.85 | Buy/Sell | ¥0.00 | -100.00% |
Henan Lingrui Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Henan Lingrui Pharmaceutical's EPS has decreased by 100.00%, going from ¥0.64 to ¥0.00. In the next year, analysts believe that EPS will reach ¥1.13 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000623 Stock Forecast | Jilin Aodong Pharmaceutical Gr... | Buy |
16
|
¥15.28 | Buy/Sell | ¥0.00 | 48.36% |
| 600422 Stock Forecast | KPC Pharmaceuticals,Inc | Buy |
18
|
¥22.64 | Buy/Sell | ¥28.00 | 10.47% |
| 000766 Stock Forecast | Tonghua Golden-Horse Pharmaceu... | - |
11
|
¥16.42 | Buy/Sell | ¥33.00 | -100.00% |
Site Navigation
.jpg)